Art

J-GLOBAL ID：201802234681839546   Reference number：18A0174657

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

化学療法と放射線療法による吐き気および嘔吐と,進行癌患者における吐き気と嘔吐の予防のための2016年MASCCとESMOガイドラインの更新

Author (19)： ROILA F. (Santa Maria Hospital, Terni, ITA) ,  MOLASSIOTIS A. (Hong Kong Polytechnic Univ., Hong Kong, CHN) ,  HERRSTEDT J. (Odense Univ. Hospital, Odense, DNK) ,  AAPRO M. (Multidisciplinary Oncology Inst., Genolier, CHE) ,  GRALLA R. J. (Albert Einstein Coll. of Medicine, New York) ,  BRUERA E. (UT MD Anderson Cancer Center, Houston) ,  CLARK-SNOW R. A. (Univ. Kansas Cancer Center, Kansas, USA) ,  DUPUIS L. L. (Univ. Toronto, Toronto, CAN) ,  EINHORN L. H. (Indiana Univ., Indianapolis, USA) ,  FEYER P. (Vivantes Clinics, Berlin, DEU) ,  HESKETH P. J. (Lahey Health Cancer Inst., Burlington, USA) ,  JORDAN K. (Martin-Luther-Univ. Halle-Wittemberg, Halle, DEU) ,  OLVER I. (Univ. South Australia, Adelaide, AUS) ,  RAPOPORT B. L. (Medical Oncology Centre of Rosebank, Johannesburg, ZAF) ,  ROSCOE J. (Univ. Rochester Medical Center, Rochester, USA) ,  RUHLMANN C. H. (Odense Univ. Hospital, Odense, DNK) ,  WALSH D. (Our Lady’s Hospice and Care Serv., Dublin, IRL) ,  WARR D. (Princess Margaret Cancer Centre, Toronto, CAN) ,  VAN DER WETERING M. (Emma Children’s Hospital, Amsterdam, NLD)
Material： Annals of Oncology  (Ann Oncol)
Volume： 27  Issue： Supplement 5  Page： v119-v133  Publication year： Sep. 2016 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *clinical practice guideline ,...
Semi thesaurus term： cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0174657&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (4)： Digestive system diseases  (GH03000W) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Radiotherapy for tumors  (GE03034K) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Reference (68)：

• Roila F, Herrstedt J, Aapro M et al. Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 2010; 21(Suppl. 5): v232-v243.
• Grunberg SM, Osoba D, Hesketh PJ et al. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity-an update. Support Care Cancer 2005; 13: 80-84.
• Jordan K, Jahn F, Aapro M. Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review. Ann Oncol 2015; 26: 1081-1090.
• Grunberg S, Chua D, Maru A et al. Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol-EASE. J Clin Oncol 2011; 29: 1495-1501.
• Saito H, Yoshizawa H, Yoshimori K et al. Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. Ann Oncol 2013; 24: 1067-1073.

Terms in the title (10)： 化学療法 ,  放射線療法 ,  吐き気 ,  嘔吐 ,  癌患者 ,  吐き気と嘔吐 ,  予防 ,  ESMO ,  ガイドライン ,  更新